A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users.
- Author:
You-Chun WANG
1
;
Si-Hong XU
;
Xiu-Hua LI
;
Ai-Jing SONG
;
Xue-Rong JIA
;
Hui ZHUANG
Author Information
- Publication Type:Journal Article
- MeSH: China; epidemiology; HIV Infections; epidemiology; Hepatitis B; epidemiology; Hepatitis C; epidemiology; Humans; Prevalence; Substance Abuse, Intravenous
- From:Chinese Journal of Epidemiology 2006;27(9):777-779
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study HIV, HBV and HCV infections in intravenous drug users.
METHODS2025 blood samples from intravenous drug users were collected from Sichuan, Hunan, Guangxi and Xinjiang regions, and tested for anti-HIV, anti-HCV, HBsAg using enzyme-linked immuno-sobent assays (ELISAs).
RESULTSThe positive rates of anti-HIV,anti-HCV and HBsAg were14.7%-30.4%, 60.7%-85.5% and 6.6%-22.4% in the intravenous drug users, respectively. The co-infection rates of HIV/HBV, HIV/HCV, HCV/HBV and HIV/HCV/HBV were 0%-0.4%, 11.6%-27.2%, 2.3%-14.3% and 1.6%-4.8% respectively in this population.
CONCLUSIONThe infection rates of HIV, HBV and HCV were higher in the intravenous drug users than that in general populations in the same regions, and HIV/HCV co-infection appeared most frequent in this population.
